Qube Research & Technologies LTD Rhythm Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $1.87 Million - $3.79 Million	110,757 Added 61.34%	291,314 $5.2 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $4.01 Million - $5.46 Million	180,557 New	180,557 $5.26 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $89,837 - $352,726	28,794 New	28,794 $119,000
Q4 2021 Feb 01, 2022	SELL	$8.62 - $13.9 $133,204 - $214,796	-15,453 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.68 - $20.72 $90,765 - $161,015	-7,771 Reduced 33.46%	15,453 $202,000
Q2 2021 Aug 13, 2021	SELL	$18.52 - $22.55 $63,931 - $77,842	-3,452 Reduced 12.94%	23,224 $455,000
Q1 2021 May 14, 2021	BUY	$20.25 - $39.49 $540,189 - $1.05 Million	26,676 New	26,676 $567,000
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $321,424 - $495,117	-15,183 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$18.13 - $30.61 $275,267 - $464,751	15,183 New	15,183 $329,000

178

69.1M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.